Status:
COMPLETED
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda
Lead Sponsor:
DBL -Institute for Health Research and Development
Collaborating Sponsors:
Ministry of Health, Uganda
Conditions:
Schistosomiasis
Malaria
Eligibility:
All Genders
8+ years
Phase:
NA
Brief Summary
The overall objective of the project is to contribute to an increased knowledge about the effect of praziquantel on schistosomiasis related morbidity and re-infection level among communities living al...
Detailed Description
In Uganda, schistosomiasis affects approximately 10% of the population and transmission takes place along all large water bodies (rivers and lakes). Morbidity control should aim at increasing the len...
Eligibility Criteria
Inclusion
- age \> 7 years Residence in project village
Exclusion
- persons treated with praziquantel within 2 weeks before recruitment
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
540 Patients enrolled
Trial Details
Trial ID
NCT00215267
Start Date
September 1 2005
End Date
October 1 2007
Last Update
February 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Musoli village
Busuyi Parish, Mayuge District, Uganda